Immunome, Inc. (IMNM)

Immunome Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	155.57	98.68	20.32	49.23	39.77	2.54
Short-Term Investments	84.56	43.47	-	-	-	-
Cash & Short-Term Investments	240.13	142.15	20.32	49.23	39.77	2.54
Cash Growth	164.92%	599.46%	-58.72%	23.80%	1463.74%	58.74%
Accounts Receivable	-	-	-	1.64	-	-
Other Receivables	-	0.29	0.85	2.67	0.85	-
Receivables	-	0.29	0.85	4.31	0.85	-
Prepaid Expenses	3.91	1.67	1.03	2.51	2.28	0.58
Other Current Assets	-	0.6	0.45	0.59	-	-
Total Current Assets	244.04	144.7	22.65	56.64	42.89	3.12
Property, Plant & Equipment	9.56	3.64	0.97	0.86	1.53	1.7
Long-Term Deferred Charges	-	-	0.33	0.33	-	-
Other Long-Term Assets	3.3	0.2	0.1	0.1	0.1	0.24
Total Assets	256.9	148.54	24.05	57.93	44.53	5.06
Accounts Payable	3.52	3.31	2.4	3.08	1.19	0.55
Accrued Expenses	25.08	7.52	4.62	4.31	1.27	0.67
Current Portion of Long-Term Debt	-	-	-	-	0.48	0.21
Current Portion of Leases	0.26	0.31	0.23	-	-	0.24
Current Unearned Revenue	9.68	10.49	-	-	-	-
Other Current Liabilities	0.99	0.2	0.09	2.34	0.1	-
Total Current Liabilities	39.53	21.83	7.33	9.73	3.04	1.67
Long-Term Debt	-	-	-	-	0.13	0.11
Long-Term Leases	2.46	1.34	0.06	-	-	-
Long-Term Unearned Revenue	-	5.49	-	-	-	-
Other Long-Term Liabilities	-	-	-	0.01	0.01	0.02
Total Liabilities	41.99	28.66	7.39	9.74	3.18	1.8
Common Stock	0.01	0	0	0	0	-
Additional Paid-In Capital	650.35	342.66	132.65	127.29	95.74	0.93
Retained Earnings	-435.52	-222.81	-116	-79.11	-54.39	-36.56
Comprehensive Income & Other	0.07	0.02	-	-	-	-
Total Common Equity	214.91	119.88	16.65	48.19	41.35	-35.63
Shareholders' Equity	214.91	119.88	16.65	48.19	41.35	3.26
Total Liabilities & Equity	256.9	148.54	24.05	57.93	44.53	5.06
Total Debt	2.72	1.65	0.29	-	0.61	0.56
Net Cash (Debt)	237.41	140.5	20.03	49.23	39.15	1.98
Net Cash Growth	162.94%	601.38%	-59.31%	25.73%	1878.42%	364.55%
Net Cash Per Share	4.43	7.08	1.65	4.27	11.55	1.81
Filing Date Shares Outstanding	62.42	59.69	12.22	12.13	10.66	1.1
Total Common Shares Outstanding	60.42	43.25	12.13	12.11	10.63	1.1
Working Capital	204.51	122.87	15.32	46.91	39.86	1.46
Book Value Per Share	3.56	2.77	1.37	3.98	3.89	-32.41
Tangible Book Value	214.91	119.88	16.65	48.19	41.35	-35.63
Tangible Book Value Per Share	3.56	2.77	1.37	3.98	3.89	-32.41
Machinery	-	5.75	3.94	3.69	3.62	1.94
Leasehold Improvements	-	0.23	0.19	0.19	0.19	0.18

Source: S&P Capital IQ. Standard template. Financial Sources.